Ads
related to: Renal Cell Carcinoma- FAQs
Find FAQs For This Treatment
Option On The Official Patient Site
- Clinical Trial Info
Review Clinical Trial Results For
This FDA-Approved Treatment Option.
- Patient Resources
Find Patient Resources
On The Official Site.
- Dosing Information
Get Dosing And Treatment
Schedule Information.
- FAQs
Search results
Wistar Scientists Develop Novel Antibody Treatment | Newswise
Newswise· 13 hours agoPHILADELPHIA — (June 04, 2024) — Advanced clear cell renal cell carcinoma (ccRCC) is a deadly form...
VHL loss attracts immune cells to tumours - Nature Reviews Nephrology
Nature· 4 days agoVHL loss is common in clear cell renal cell carcinoma (ccRCC) and triggers a pseudohypoxic state in mutated cells. A study by Jeffrey ...
GRIT and Quangang announce IL-2 T-cell therapy partnership
Pharmaceutical Technology via Yahoo Finance· 1 day agoQuanqi (125SER) is a marketed human Interleukin-2 used in treating solid tumours including renal ...
Moderna & Merck Announce 3-Year Data For mRNA-4157 (V940) in Combination With KEYTRUDA(R)...
Digital Journal· 1 day agoAt a median planned follow-up of the Phase 2b study at 34.9 months, mRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of recurrence or death by 49% and the risk of distant metastasis ...
New Study Finds Increased Disparities in Cancer Su | Newswise
Newswise· 4 days agoA new study led by researchers at the American Cancer Society (ACS) shows increased disparities in...
GRIT and Quangang Forge Strategic Partnership to Accelerate Localization of Interleukin-2
The Pilot News· 4 days agoShanghai Grit Biotechnology Co., Ltd. (GRIT) and Shandong Quangang Pharmaceutical Co., Ltd. (Quangang) announced the establishment of a formal strategic partnership to leverage both parties' ...
Exelixis (EXEL) Down 6.6% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 5 days agoCabometyx (cabozantinib) generated revenues of $376.4 million, which missed the Zacks Consensus...
DRAIC mediates hnRNPA2B1 stability and m6A-modified IGF1R instability to inhibit tumor progression -...
Nature· 6 days agoType 1 insulin-like growth factor receptor (IGF1R) plays an important role in cancer, however, posttranscriptional regulation such as N6-methyladenosine (m6A) of IGF1R remains unclear. Here, ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 3 days agoWerewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 2 days agoThe rolling BLA submission, initiated in December 20233 with timelines pre-agreed with the FDA, was based on Telix’s successful global Phase III ZIRCON4 study in ccRCC. The...
Ads
related to: Renal Cell Carcinoma